Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06503809 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
A NA study of Diabetes Mellitus, Type 1, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT06503809 is a NA study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 58 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06503809, a NA study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite strong evidence that tight control of blood sugar reduces the risk of diabetes complications, most people with type 1 diabetes do not achieve recommended blood sugar targets. This randomized controlled trial will test whether a very-low- carbohydrate ketogenic diet can effectively and safely improve blood sugar control in adults with type 1 diabetes.
Conditions Studied
Interventions
- BEHAVIORAL Ketogenic Diet
- BEHAVIORAL Standard Diet
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06503809
The ClinicalTrials.gov registry entry for NCT06503809 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Ketogenic Diet is the first listed.
NCT06503809 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06503809 about?
NCT06503809 is a clinical study titled "Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes". Despite strong evidence that tight control of blood sugar reduces the risk of diabetes complications, most people with type 1 diabetes do not achieve recommended blood sugar targets. This randomized controlled trial will test whether a very-low- carbohydrate ketogenic diet can effectively and safely...
What is the current status of trial NCT06503809?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2024-08-12. Estimated completion is 2030-03-31.
What conditions does trial NCT06503809 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT06503809?
The interventions under investigation include: Ketogenic Diet (BEHAVIORAL), Standard Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT06503809?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06503809 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
-
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
RECRUITING · NA
-
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
RECRUITING · NA
-
Closed Loop and Education for Hypoglycemia Awareness Restoration
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.